Coral Labs.

31
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
473.90
4.15 (0.88%)
BSENSE

Dec 05

BSE+NSE Vol: 103

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 37.47% vs 7.09% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 61.58% vs 326.03% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 48,700.00% vs -99.94% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 52.99% vs 144.97% in Mar 2024

Compare Profit and Loss Results of Coral Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
115.00
2.00
113.00
5,650.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
115.00
2.00
113.00
5,650.00%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-9.00
12.00
133.33%
Raw Materials Consumed
49.00
11.00
38.00
345.45%
Power & Fuel Cost
3.00
0.00
3.00
0%
Employee Cost
14.00
3.00
11.00
366.67%
Operating Expenses
4.00
0.00
4.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
0.00
2.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
2.00
3.00
150.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
9.00
79.00
877.78%
Operating Profit (PBDIT) excl Other Income
26.00
-7.00
33.00
471.43%
Other Income
9.00
1.00
8.00
800.00%
Operating Profit (PBDIT)
35.00
-6.00
41.00
683.33%
Interest
0.00
2.00
-2.00
-100.00%
Profit before Depriciation and Tax
35.00
-8.00
43.00
537.50%
Depreciation
2.00
0.00
2.00
0%
Profit Before Taxation & Exceptional Items
33.00
-8.00
41.00
512.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
32.00
-8.00
40.00
500.00%
Provision for Tax
8.00
-1.00
9.00
900.00%
Profit After Tax
24.00
-7.00
31.00
442.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
147.00
-14.00
161.00
1,150.00%
Profit Available for appropriations
171.00
-22.00
193.00
877.27%
Appropriations
171.00
-22.00
193.00
877.27%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
67.61
-2.06
69.67
3,382.04%
Profit And Loss - Net Sales
Net Sales 115.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.47% vs 7.09% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 61.58% vs 326.03% in Mar 2024

Profit And Loss - Interest
Interest 0.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 48,700.00% vs -99.94% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 24.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 52.99% vs 144.97% in Mar 2024